Naprod Life Sciences maintains an international manufacturing accreditation register for its sterile-injectables facility at MIDC Tarapur, Boisar, Maharashtra. As the underlying certificates are digitized, 15 of the 21 international accreditations on the register are now confirmed from the issued certificate held on file, including EU-GMP, WHO-GMP, ANVISA (Brazil), INVIMA (Colombia), the EAEU GMP certificate, the UAE Ministry of Health and Prevention, and Bahrain’s NHRA, together with GMP approvals across East and Southern Africa (Kenya, Tanzania, Uganda, Zimbabwe, Ethiopia, and Malawi), and a registration covering Yemen.
Each certification is issued, scoped, and renewed independently by its issuing authority, and covers the manufacturing site’s quality systems and process controls rather than any individual product. The remaining 6 national approvals on the register are held on the company’s internal list and are being digitized for publication with the same detail: issuing body, certificate scope, and current validity. Separately, the site’s India domestic manufacturing and wholesale licences (CDSCO / State FDA) are current.
The full register, with issuing body, scope, and validity dates published as each certificate is confirmed, is maintained on the Quality & Regulatory section of this site. Certificates confirmed from documents on file are always shown distinctly from entries still being digitized; the two are never presented as equivalent.